Vinge has advised Oncorena Holding AB. Oncorena Holding AB has conducted a share issue amounting to approximately SEK 133 million. The capital raised from the issue...
Oncorena Holding AB Completes SEK 133 Million Share Issue
Cantargia Sells CAN10 Immunology Program to Otsuka Pharmaceutical
Vinge has advised Cantargia AB. Cantargia AB (publ) has announced the sale of its early-clinical stage IL1RAP immunology program CAN10 to Japanese healthcare company Otsuka Pharmaceutical....
Trianon’s Sale of Properties
Vinge advised Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) secured the sale of properties with a total agreed property value of SEK 1,062 million. Fastighets...
Pharming’s Public Offer to Abliva
Vinge advised Abliva on the deal. Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of...
Cantargia’s Rights Offering
Vinge advised Cantargia on the deal. Cantargia AB (publ) secured a rights offering of approximately SEK 170 million. Cantargia develops antibody based therapies against the target...
SunMind’s Acquisition of Helios Nordic Energy AB
Vinge advised Vinci Concessions SAS and its subsidiary SunMind SAS on the deal. Vinci Concessions SAS and its subsidiary SunMind SAS secured the acquisition of Helios...
Trianon’s Shares Offering
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a directed share issue of SEK 184 million and a tender offer for...
Trianon’s Tender Offering
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a partial tender offer for outstanding subordinated perpetual floating rate callable sustainable capital...
Cantargia’s Shares Offering
Vinge advised Cantargia AB on the deal. Cantargia AB (publ) completed a directed share issue of approximately SEK 59 million (approx. $5.4 million) to a number of...
Infant Bacterial Therapeutics AB’s Rights Offering
Vinge advised Infant Bacterial Therapeutics AB on the offering. Infant Bacterial Therapeutics AB (publ) completed its rights offering of approximately SEK 100 million. IBT is addressing...
Procuritas’ €407 Million Fundraising
Vinge has advised Procuritas on the deal. The fund has received total commitments of EUR 407 million. PCI VII will continue Procuritas’ successful investment strategy of...
BHG Group’s SEK 800 Million Directed Share Issue
Vinge advised BHG Group AB on the deal. BHG Group AB has successfully carried out a directed new issue of 39,024,390 shares, at a subscription price...